Clinical Trial Update: COVID-19 Antibody Responses in Cystic Fibrosis

View source ↗

Summary

This clinical trial update reports on the status of a study examining COVID-19 antibody responses in people with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University Hospital, Motol | Conditions: Cystic Fibrosis | Status: ACTIVE_NOT_RECRUITING